16 results
6-K
EX-99.1
GNFT
Genfit
6 Dec 23
Current report (foreign)
11:30am
and improve patient satisfaction. It would also lead to a liver biopsy failure rate decrease, maintaining timely and cost-efficient completion of MASH clinical … clinical trials, as well as reduce likelihood of study- related complications and improve patient satisfaction. The use of certain words, including
6-K
EX-99.1
dc4o9f8rnbogi g32y
28 Sep 20
GENFIT and LabCorp Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver Disease
7:00am
20-F
EX-4.9
tw2al81nsxeravw70rc
27 May 20
Annual report (foreign)
12:35pm
20-F
zwh 47akk
27 May 20
Annual report (foreign)
12:35pm
424B4
meg5 qdm6
27 Mar 19
Prospectus supplement with pricing info
4:12pm
F-1/A
EX-1.1
iuafnfshf 0y
14 Mar 19
Registration statement (foreign) (amended)
12:54pm
F-1/A
fddzrbi326g0aqpp
14 Mar 19
Registration statement (foreign) (amended)
12:54pm
F-1
doolf80lu4ay7
27 Feb 19
Registration statement (foreign)
2:11pm
DRS/A
gv6awg2ty2fnminea iz
15 Feb 19
Draft registration statement (amended)
12:00am
DRS/A
ovfmsx0 dcdmu
21 Dec 18
Draft registration statement (amended)
12:00am
DRS
v0upwlbnm0jioq9l3
16 Nov 18
Draft registration statement
12:00am
- Prev
- 1
- Next